IL1B and esophageal squamous cell carcinoma: Moreover, to evaluate the clinical significance of these findings, the predictive capacity of IL-1B regarding clinical outcomes and treatment responses in patients with esophageal SCC was assessed utilizing immunohistochemistry (IHC) analysis.